Trials / Completed
CompletedNCT02358473
Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer
Open-label, Multicenter Phase 1 Study of Mogamulizumab (KW-0761) in Combination With Docetaxel in Previously Treated Subjects With Non-small Cell Lung Cancer (NSCLC)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Kyowa Kirin, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety of mogamulizumab in combination with docetaxel in adult subjects with previously treated locally advanced or metastatic non-small cell lung cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | mogamulizumab | Mogamulizumab will be administered by IV infusion. |
| DRUG | Docetaxel | Docetaxel will be administered by IV infusion. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2015-02-09
- Last updated
- 2024-09-19
- Results posted
- 2018-11-30
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02358473. Inclusion in this directory is not an endorsement.